SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-21-000046
Filing Date
2021-08-09
Accepted
2021-08-09 16:25:47
Documents
13
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20210809x8k.htm   iXBRL 8-K 44317
2 EX-99.1 amph-20210809ex99157e289.htm EX-99.1 736734
  Complete submission text file 0001297184-21-000046.txt   934849

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20210809.xsd EX-101.SCH 3210
4 EX-101.LAB amph-20210809_lab.xml EX-101.LAB 15497
5 EX-101.PRE amph-20210809_pre.xml EX-101.PRE 10521
6 EXTRACTED XBRL INSTANCE DOCUMENT amph-20210809x8k_htm.xml XML 4641
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 211156855
SIC: 2834 Pharmaceutical Preparations